MicroRNAs in biliary diseases

doi:10.3748/wjg.v18.i43.6189

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 43

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4478)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

434

HTML

3585

Figures (1-2)

235

Tables (1-1)

224

Sum=4478

Nov 21, 2012 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (23)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Guidelines For Basic Science

World J Gastroenterol. Nov 21, 2012; 18(43): 6189-6196
Published online Nov 21, 2012. doi: 10.3748/wjg.v18.i43.6189

Full Size Figure Download Figure

Figure 2 Role of miRNA-506 in the etiopathogenesis of primary biliary cirrhosis. Different risk factors could induce genetic alterations leading to anion exchange 2 (AE2) downregulation in primary biliary cirrhosis (PBC) cholangiocytes. miRNA-506 is overexpressed in PBC cholangiocytes, thus resulting in the inhibition of both AE2 protein translation and subsequent Cl^-/HCO₃^- activity, and impairing the biliary secretory functions.

Citation: Munoz-Garrido P, Fernandez-Barrena MG, Hijona E, Carracedo M, Marín JJG, Bujanda L, Banales JM. MicroRNAs in biliary diseases. World J Gastroenterol 2012; 18(43): 6189-6196
URL: https://www.wjgnet.com/1007-9327/full/v18/i43/6189.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i43.6189